Skip to content

The effect of metoclopramide, propofol and dexamethasone in controlling nausea and vomitin for cesarean section

The effect of metoclopramide, propofol and dexamethasone in controlling nausea and vomiting during spinal anesthesia for cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016072729103N1
Enrollment
144
Registered
2016-09-18
Start date
2015-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: nausea vomiting. Condition 2: Vomiting. nausea and vomiting Postprocedural disorder of digestive system, unspecified

Interventions

Intervention 1: Metoclopramide 0.1 mg/kg IV. Intervention 2: Dexamethasone 150 ug/kg IV. Intervention 3: Propofol 0.1 mg/kg IV. Intervention 4: Normal saline 2ml IV.
Treatment - Drugs
Placebo
Dexamethasone 150 ug/kg IV
Propofol 0.1 mg/kg IV
Normal saline 2ml IV
Metoclopramide 0.1 mg/kg IV

Sponsors

Deputy of research and technology at azad university of Tehran
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: lack of hypertension in pregnancy; motion sickness; active bleeding; fetal distress; placental abruption; placenta Peravia; history of the gastrointestinal disease; systolic blood pressure less than 90 or hypotension more than 30% of the initial pressure.There is not any exclusive criteria.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Nausea. Timepoint: Recovery; first,third, sixth and twelfth hour after surgery and before discharge. Method of measurement: mild modereate sever.;Vomiting. Timepoint: Recovery; first, third, sixth and twelfth hour after surgery and before discharge. Method of measurement: yes or no.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sarabandi

Amiralmomenin hospital

drsarabandi@yahoo.com+98 21 5534 6262

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026